Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2014

Nov 20, 2014

30071_dirs_2014-11-20_4831009c-dd7a-430c-aa3c-636cfe33e5ac.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2014-11-18

Reporting Person: FARRELL PETER C (Director, Chairman of the Board)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-11-18 ResMed Common Stock M 36000 $15.52 Acquired 292375 Direct
2014-11-18 ResMed Common Stock S 36000 $52.393 Disposed 256375 Direct
2014-11-19 ResMed Common Stock A 2442 Acquired 258817 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-11-18 ResMed Common Stock Options $15.52 M 36000 Disposed 2015-11-20 ResMed Common Stock (36000) Direct
2014-11-19 ResMed Common Stock Options $52.02 A 11815 Acquired 2021-11-19 ResMed Common Stock (11815) Direct

Holdings (Non-Derivative)

Security Shares Ownership
ResMed Common Stock 22783 Indirect
ResMed Common Stock 200000 Indirect
ResMed Common Stock 200000 Indirect

Footnotes

F1: The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.

F2: Represents date options first became exercisable. Options vest 1/4 annually on the anniversary of the grant.

F3: Options vest in full (i) on the first Nov. 11 following the grant date or (ii) the first annual shareholder's meeting following grant date. Options have a required holding period until the earlier of (i) Nov. 11 of the third year following grant date or (ii) six months following termination of directorship.

F4: This transaction was executed in multiple trades at prices ranging from $51.91 to $52.393. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.

F5: Securities held by Larry Poster, Trustee of the Peter C. Farrell Grantor Retained Annuity Trust.